Clinical Trials Logo
  1. Home
  2. Severe Pneumonia
  3. NCT01068990
  4. Details
NCT01068990 Clinical Trial

Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients

Severe Pneumonia Clinical Trial

Official title:
Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT01068990
Other study ID # AICUP
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 2010
Est. completion date February 28, 2028

Study information
Verified date April 2024
Source Asan Medical Center
Contact Sang-Ho Choi, MD
Phone +82-2-3010-3304
Email sangho@amc.seoul.kr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study is a prospective observation study for lower respiratory tract infections in medical intensive care unit. Microbiologic and clinical characteristics and outcomes of patients with severe pneumonia in medical intensive care unit will be monitored and analyzed.

Description:

All patients admitting medical ICU will be monitored for pneumonia. Both community-acquired (including health-care associated pneumonia) and hospital-acquired pneumonia will be included. Collecting data will include patient demographic characteristics, clinical features, microbiological characteristics including molecular work, and outcome.

Recruitment information / eligibility
Status Recruiting
Enrollment 300
Est. completion date February 28, 2028
Est. primary completion date February 28, 2028
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria: - Patients admitting medical ICU with pneumonia - Medical ICU admitted patients who is developed new pneumonia Exclusion Criteria: - Patients already treated more than 48 hours for pneumonia in transferring hospital and no causative organism is isolated

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Korea, Republic of Asan Medical Center Seoul

Sponsors (1)
Lead Sponsor Collaborator
Asan Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

Outcome
Type Measure Description Time frame Safety issue
Primary Identification of etiology of pneumonia 7 day from the time of pneumonia diagnosis
Secondary Pneumonia-related death 1 month
See also
  Status Clinical Trial Phase
Recruiting NCT06114784 - Microbiome and Host Susceptibility in Severe Pneumonia, a Prospective, Multicenter, Cohort Study
Completed NCT03870243 - Feasibility and Acceptability Followed by Effectiveness of bCPAP for Treatment of Children Aged 1-59 Months With Severe Pneumonia in Ethiopia N/A
Completed NCT05158842 - Treatment of COVID-19 Positive/Negative Bangladeshi Adults With Severe Respiratory Complaints by a Locally Made bCPAP: Feasibility Study N/A
Suspended NCT04310865 - Yinhu Qingwen Granula for the Treatment of Severe CoVID-19 Phase 2/Phase 3
Completed NCT04457505 - One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19
Terminated NCT04794803 - Reparixin in COVID-19 Pneumonia - Efficacy and Safety Phase 2/Phase 3
Completed NCT03831906 - Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries (TB-Speed Pneumonia) N/A
Recruiting NCT05768204 - Research on the Treatment of Severe Community-acquired Pneumonia in Children Phase 4
Recruiting NCT04359667 - Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab
Not yet recruiting NCT04395066 - Molecular Diagnosis and Prognosis of Severe Pulmonary Infection Immunosuppressed Hosts
Not yet recruiting NCT05143593 - Species-specific Bacterial Detector for Fast Pathogen Diagnosis of Severe Pneumonia N/A
Completed NCT05663905 - Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients Phase 4
Not yet recruiting NCT04282928 - Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells for the Treatment of Severe Viral Pneumonian Phase 1
Completed NCT01192789 - Community Case Management of the Severe Pneumonia With Oral Amoxicillin in Children 2-59 Months of Age N/A
Completed NCT00455468 - Randomized Controlled Trial (RCT) in Children With Severe Pneumonia N/A
Completed NCT03588377 - Impact of Pulse Oximetry on Hospital Referral Acceptance in Children Under 5 With Severe Pneumonia N/A
Recruiting NCT04955756 - Early Identification and Severity Prediction of Acute Respiratory Infectious Disease N/A
Recruiting NCT04882436 - Construction of Special Disease Cohort Database and Biological Sample Holographic Database of Severe Pneumonia
Not yet recruiting NCT03891212 - The Effect of Prone Position Drainage on the Efficacy of Severe Pneumonia，a Multicenter Randomized Controlled Trial N/A